Rani Therapeutics

(NASDAQ) RANI

Current Price$0.80

Market Cap$80.13M

Since IPO (2021)-93%

5 YearN/A

1 Year+40%

1 Month-27%

Rani Therapeutics Financials at a Glance

Market Cap

$80.13M

Revenue (TTM)

$3.17M

Net Income (TTM)

-$29.44M

EPS (TTM)

-$0.41

P/E Ratio

-1.96

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.80

Volume

Open

$0.77

Price

$0.80

Volume

Open

$0.77

Previous Close

$0.80

Daily Range

$0.76 - $0.81

52-Week Range

$0.39 - $3.87

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.80

Volume

Open

$0.77

Previous Close

$0.80

Daily Range

$0.76 - $0.81

52-Week Range

$0.39 - $3.87

Estimated Earnings Date

Aug 6, 2026

RANI News

Rani (RANI) Q2 Net Loss Improves 16%

Motley Fool Markets TeamAug 7, 2025

people representing three generations playing hula hoop together and smiling

This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More

Jeffrey LittleOct 4, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rani Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Talat Imran

Website

www.ranitherapeutics.com

Headquarters

San Jose, CA 95131, US

RANI Financials

Key Financial Metrics (TTM)

Gross Margin

95%

Operating Margin

-11%

Net Income Margin

-9%

Return on Equity

-232%

Return on Capital

-91%

Return on Assets

-57%

Earnings Yield

-51.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$80.13M

Shares Outstanding

99.91M

Volume

Avg. Volume

1.14M

Financials (TTM)

Gross Profit

$733.00K

Operating Income

-$38.31M

EBITDA

-$37.16M

Operating Cash Flow

-$18.71M

Capital Expenditure

-$88.00K

Free Cash Flow

-$18.80M

Cash & ST Invst.

$49.71M

Total Debt

$4.32M

Rani Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.71M

+893.0%

Gross Profit

$1.55M

+799.4%

Gross Margin

90.57%

N/A

Market Cap

$80.13M

N/A

Market Cap/Employee

$763.14K

N/A

Employees

105

N/A

Net Income

-$7.03M

+3.2%

EBITDA

-$7.77M

+32.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$43.40M

+173.8%

Total Debt

$3.94M

-84.6%

Accounts Receivable

$2.11M

+252.2%

Inventory

$0.00

N/A

Long Term Debt

$2.48M

-73.4%

Short Term Debt

$1.46M

-91.1%

Return on Assets

-56.75%

N/A

Return on Invested Capital

-91.09%

N/A

Free Cash Flow

-$6.51M

+20.6%

Operating Cash Flow

-$6.50M

+20.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$7.78+1.04%

SGMOSangamo Therapeutics, Inc.

SGMOSangamo Therapeutics, Inc.$0.15+0.00%

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.$1.59+7.43%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.27+4.10%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$3.71-0.27%

APLTApplied Therapeutics, Inc.

APLTApplied Therapeutics, Inc.$0.10+0.00%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.74-0.57%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$5.73+0.22%

NOKNokia

NOKNokia$14.09+0.05%

EDHLEverbright Digital

EDHLEverbright Digital$5.98+0.71%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.01+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.12+0.09%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.83-0.10%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$717.12+0.03%

Questions About RANI

What is the current price of Rani Therapeutics?

Rani Therapeutics is trading at $0.80 per share.

What is the 52-week range for Rani Therapeutics?

Over the past 52 weeks, Rani Therapeutics has traded between $0.39 and $3.87.

How much debt does Rani Therapeutics have?

As of the most recent reporting period, Rani Therapeutics reported total debt of $3.94M.

How much cash does Rani Therapeutics have on hand?

Rani Therapeutics reported $9.84M in cash and cash equivalents in its most recent financial results.

What is Rani Therapeutics’s dividend yield?

Rani Therapeutics does not currently have a dividend yield.

Rani Therapeutics

Rani Therapeutics Financials at a Glance

RANI News

Rani (RANI) Q2 Net Loss Improves 16%

This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Rani Therapeutics

RANI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Rani Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RANI

What is the current price of Rani Therapeutics?

What is the 52-week range for Rani Therapeutics?

How much debt does Rani Therapeutics have?

How much cash does Rani Therapeutics have on hand?

What is Rani Therapeutics’s dividend yield?

Premium Investing Services